跳至主要内容
临床试验/NCT03398031
NCT03398031Unknown3 期

Magnesium Supplement in Early Pregnancy After ICSI

Ain Shams University1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2017年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
180
试验地点
1
主要终点
1st trimesteric abortion

研究概览

简要总结

Daily supplement of magnesium after biochemical diagnosis of pregnancy in females pregnant after ICSI and through out 1st trimester

详细描述

a fall of magnesium levels at 2-3 weeks of gestation. This drop of magnesium concentration is larger following IVF as compared to spontaneous pregnancies.

so magnesium supplement start after biochemical diagnosis of pregnancy and throughout the 1st trimester

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age 25_38 years
  • BMI 25_30
  • females pregnant after ICSI after biochemical diagnosis of pregnancy

排除标准

  • females with poor ovarian reserve and poor responders
  • abnormality in uterine cavity detected by hysteroscopic evaluation pre ICSI and not treated
  • hydrosalpinx

研究组 & 干预措施

placebo

Placebo Comparator

90 female pregnant after ICSI after biochemical diagnosis of pregnancy will receive placebo oral tablet

干预措施: Placebo Oral Tablet (Drug)

Magnesium supplement

Active Comparator

90 female pregnant after ICSI after biochemical diagnosis of pregnancy will receive 500 mg magnesium supplement

干预措施: Magnesium Oxide (Drug)

结局指标

主要结局

1st trimesteric abortion

时间窗: 13 week of gestation

Either spontaneous or missed abortion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Radwa Rasheedy Ali

lecturer

Ain Shams University

研究点 (1)

Loading locations...

相似试验